Home » Stocks » INM

InMed Pharmaceuticals, Inc. (INM)

Stock Price: $4.11 USD -0.06 (-1.44%)
Updated Jan 21, 2021 12:11 PM EST - Market open
Market Cap 29.85M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 5.22M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 21
Last Price $4.11
Previous Close $4.17
Change ($) -0.06
Change (%) -1.44%
Day's Open 4.33
Day's Range 4.05 - 4.37
Day's Volume 13,448
52-Week Range 2.97 - 4.87

News

NASDAQ - 3 months ago

InMed Pharmaceuticals, a clinical stage biotech developing cannabinoid-based products, announced terms for its IPO on Thursday.

About INM

InMed Pharmaceuticals, a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of orofacial pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermat... [Read more...]

Industry
Biotechnology
CEO
Eric Adams
Stock Exchange
NASDAQ
Ticker Symbol
INM
Full Company Profile

Financial Performance

Financial Statements